Gonorrhea treatment: New antibiotic shows promise for drug-resistant infection

A new antibiotic has proven as effective as the last remaining recommended treatment for gonorrhea, helping to assuage mounting fears among public health experts about the emergence of drug-resistant strains of the sexually transmitted infection. Gonorrhea is the second most common STI in the U.S. and has developed resistance to all antibiotics used to treat it, except for the recommended combined therapy of an injection of the antibiotic ceftriaxone with one dose of azithromycin pills.

According to an Innoviva representative, the company aims to file for approval of the antibiotic with the Food and Drug Administration “as quickly as practicably possible.” Innoviva expects an expedited review, meaning the FDA would take about six months to issue a decision. Zoliflodacin belongs to a new class of antibiotics, and attacks gonorrhea in a novel way.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New York City’s new goal: Everyone lives to at least 83Public health experts hope New York’s plan to improve life expectancy can be a model for other cities as the nation grapples with a spike in premature deaths.
Source: washingtonpost - 🏆 95. / 72 Read more »

Expert joins CBS New York to discuss new sickle cell treatmentThe FDA is one step closer to approving a groundbreaking new treatment for sickle cell disease. Dr. Kerry Morrone, the director of the pediatric sickle cell program at Montefiore, joined CBS New York to discuss the treatment. Read more: https://cbsloc.
Source: CBSNewYork - 🏆 268. / 63 Read more »